Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.32 GBX | +12.74% | +11.04% | +18.20% |
03:42pm | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
02:23pm | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.20% | 3.2Cr | |
-50.34% | 249.94Cr | |
+26.27% | 199.66Cr | |
-9.47% | 150.69Cr | |
+28.65% | 132.79Cr | |
-16.57% | 96Cr | |
0.00% | 80Cr | |
-30.63% | 79Cr | |
-23.56% | 64Cr | |
+18.87% | 58Cr |
- Stock Market
- Equities
- RENX Stock
- News Renalytix Plc
- Transcript : Renalytix Plc, Q1 2023 Earnings Call, Nov 30, 2022